Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beijing Tiantan Hospital | OTHER |
| Beijing Shijitan Hospital, Capital Medical University | OTHER |
| Beijing Hospital | OTHER_GOV |
| Peking Union Medical College Hospital |
Not provided
Not provided
Not provided
Not provided
Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| the excess weight loss effect of different metabolic surgeries after 1year | Percent excess weight loss (%EWL), %EWL=[(initial weight)-(post-op weight)]/[(initial weight)-(ideal weight)] (in which "ideal weight" is defined by the weight corresponding to a BMI of 25 kg/m2) | 1 year after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| the adverse events rate of different metabolic surgeries | show the surgical safety by 30 days follow-up according to guideline（such as: bleeding, leak, obstruction, re-operation for complication） | 30 days after surgery |
| the excess weight loss effect of metabolic surgery with long-time follow-ups |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
patients with morbid obesity who are suitable and willing to accept metabolic surgical procedure and also agree with the registry
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Beijing Friendship Hospital | Beijing | Beijing Municipality | 100050 | China |
Not provided
| ID | Term |
|---|---|
| D008659 | Metabolic Diseases |
| ID | Term |
|---|---|
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| OTHER |
| Shanxi Dayi Hospital | OTHER |
| The Second Hospital of Hebei Medical University | OTHER |
| Tianjin Medical University General Hospital | OTHER |
| Inner Mongolia People's Hospital | OTHER |
| Henan Provincial People's Hospital | OTHER |
| Qilu Hospital of Shandong University | OTHER |
| The First Hospital of Hebei Medical University | OTHER |
| The Second People's Hospital of Xinxiang Henan | UNKNOWN |
| Tangshan Gongren Hospital | OTHER |
| Tianjin Nankai Hospital | OTHER |
| Tianjin First Central Hospital | OTHER |
Not provided
Not provided
Not provided
Percent excess weight loss (%EWL), %EWL=[(initial weight)-(post-op weight)]/[(initial weight)-(ideal weight)] (in which "ideal weight" is defined by the weight corresponding to a BMI of 25 kg/m2) |
| 3 years |
| the excess weight loss effect of metabolic surgery with long-time follow-ups | Percent excess weight loss (%EWL), %EWL=[(initial weight)-(post-op weight)]/[(initial weight)-(ideal weight)] (in which "ideal weight" is defined by the weight corresponding to a BMI of 25 kg/m2) | 5 years |
| the excess weight loss effect of metabolic surgery with long-time follow-ups | Percent excess weight loss (%EWL), %EWL=[(initial weight)-(post-op weight)]/[(initial weight)-(ideal weight)] (in which "ideal weight" is defined by the weight corresponding to a BMI of 25 kg/m2) | 10 years |
| the glycemic control level of metabolic surgery with long-time follow-ups | the change of HbA1c, glucose level, C-peptide and insulin levels | 1 year after surgery |
| the glycemic control level of metabolic surgery with long-time follow-ups | the change of HbA1c, glucose level, C-peptide and insulin levels | 3 year after surgery |
| the glycemic control level of metabolic surgery with long-time follow-ups | the change of HbA1c, glucose level, C-peptide and insulin levels | 5 year after surgery |
| the glycemic control level of metabolic surgery with long-time follow-ups | the change of HbA1c, glucose level, C-peptide and insulin levels | 10 year after surgery |